Marketing communications agency, Onyx Health has been appointed by Newcastle upon Tyne, UK-based OLM Diagnostics to develop and implement a marketing strategy to raise awareness of its diagnostic-led approach to fungal and bacterial testing.
Frazer Thompson, operations director and OLM Diagnostics, said: “Having met the team, I could immediately see the value in what Onyx Health offers.
“In a short timeframe, they’ve already developed impactful messages and branding that has resonated well with our customers.”
The anti-fungal resistance-focussed organisation has developed a range of fungal and bacterial diagnostic tests into current treatment pathways to reduce to the rate of drug resistant infections.
Karen Winterhalter, Onxy’s health director, said: “The North East has gained international recognition for healthcare innovation, and OLM Diagnostics is a great example of this.
“Our knowledge of the healthcare market enables us to develop and implement sales and marketing strategies to help companies navigate the complexities of global healthcare markets.”
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...